Potent and Selective Oral STAT6 Degrader, KT-621, Inhibits IL-4 and IL-13 Functions in Human Cells and Blocks Th2 Inflammation in House Dust Mite Models of Asthma Prophylactically and Therapeutically

May 19, 2025

Potent and Selective Oral STAT6 Degrader, KT-621, Inhibits IL-4 and IL-13 Functions in Human Cells and Blocks Th2 Inflammation in House Dust Mite Models of Asthma Prophylactically and Therapeutically

American Thoracic Society (ATS) 2025

Amy Wang, Bin Yang, Karen Yuan, Alamgir Hossain, Huijun Dong, Anand Ramanathan, Bruce Follows, Sean Zhu, Chris Browne, Andreas Harsch, Ralf Schmidt, Mike Weis, Rupa Sawant, Bradley Enerson, Jing Yuan, Richard Miller, Matt Weiss, Nello Mainolfi

Kymera ATS 2025 Poster Image
Area of Focus
Immunology
Programs
STAT6 (KT-621)
Development Stage
Pre-clinical Data
Share
LinkedInXFacebookEmailCopy Link